GC Cell Corp banner

Intrinsic Value

The intrinsic value of GC Cell Corp (144510) under the Base Case is 10 783.57 KRW per share. Compared with the current market price of 10 210 KRW, the stock appears Undervalued by 5% .

The intrinsic value is calculated using the DCF method. Operating margin recovers from -8.3% last year to 7% by 2031. If operating margin stayed at its five-year average of 4.5%, the estimate would be about ₩7,382.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩10 783.57
Undervaluation 5%
Intrinsic Value
Price ₩10 210
Alert me when GC Cell Corp is below its intrinsic value
Today ₩8 626.86 · 15.5% below the current price

GC Cell Corp is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to GC Cell Corp

Fundamental Analysis

What GC Cell Does

Biotechnology Health Care

GC Cell Corp is a South Korean biotech company focused on cell-based medicines and related medical services. It develops and sells therapies made from living cells, with an emphasis on treatments that support the immune system and regenerative medicine. It also works with hospitals and medical partners that handle cell collection, processing, and storage for treatment use.

Headquarters
Korea KR
IPO date
Jun 23, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
GC Cell Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GC Cell Corp stock?

The intrinsic value for GC Cell Corp (144510) under the Base Case is 10 783.57 KRW.

Is GC Cell Corp stock undervalued or overvalued?

Compared with the current market price of 10 210 KRW, the stock appears Undervalued by 5% .

Back to Top